Oestrogen supports hair growth and protects the scalp from inflammation. When oestrogen declines during perimenopause and menopause, that protection falls away. The result is increased scalp inflammation, greater DHT sensitivity in follicles, and accelerated hair thinning — even in women with normal hormone levels.
Oestrogen prolongs the hair growth phase and suppresses scalp inflammation. As oestrogen declines in perimenopause, both protections weaken simultaneously. DHT — which drives follicle miniaturisation — becomes relatively more dominant. Scalp inflammation, no longer suppressed by oestrogen, sensitises follicles to DHT further. This compound effect explains why hair loss often accelerates sharply in the 40s and 50s.
Oestrogen does two important things for hair:
As oestrogen declines in perimenopause (typically starting in the mid-40s), both protections reduce. The growth phase shortens. Scalp inflammation is no longer suppressed. The result is a compounding vulnerability.
Dihydrotestosterone (DHT) is a potent androgen derived from testosterone via the enzyme 5-alpha reductase. In follicles with genetic sensitivity to DHT, it binds to androgen receptors and progressively shrinks the follicle over successive growth cycles — a process called miniaturisation.
Key nuance: DHT sensitivity, not DHT level, determines impact. Inflammation is what increases that sensitivity. Two women with identical DHT levels can have dramatically different hair loss outcomes based on the inflammatory state of their scalp. Treating DHT alone often fails because it doesn't address the inflammation making follicles vulnerable in the first place.
Elevated cortisol (from chronic stress, poor sleep, or systemic illness) promotes inflammatory cytokine release in scalp tissue. It also suppresses oestrogen — compounding the hormonal problem. This is why stress and hormonal decline interact so badly for hair health: they're both amplifying the same inflammation pathway.
Every hormonal pathway that contributes to hair loss — oestrogen decline, DHT, cortisol — feeds into the same downstream mechanism: chronic scalp inflammation. The inflammation is the common pathway. Addressing it directly, rather than chasing each hormonal factor individually, is often more effective.
ThriivX H3's Kannopia-Active works at this inflammation layer — modulating the scalp's endocannabinoid system to reduce the cytokine activity that makes follicles vulnerable to DHT, regardless of hormonal context.
ThriivX H3 addresses the common pathway that oestrogen decline, DHT, and cortisol all feed into.
Shop ThriivX H3 →Most supplements address nutrient deficiency. ThriivX H3 addresses scalp inflammation — the upstream trigger that's driving follicle miniaturization.
Get ThriivX H3 →Results vary. Consult your physician before starting any supplement.